Psychiatry & Neurology, Neuromuscular Medicine · Pittsburgh, PA
NPI
1457555773
Since 2007
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
532 S Aiken Ave Bldg Suite300
Pittsburgh, PA, 15232
Phone (412) 681-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
816 services
Medicare patients, 2024
179
Average age 70
Drug cost, 2024
$3.4M
1,037 prescriptions
Company payments, 2023
$34.12
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tawfiq Al Lahham was code 95886 (electrical nerve conductivity), 131 times for 81 patients. In total Tawfiq Al Lahham billed 816 services in 27 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Facility | 131 | 81 | $31.99 | $4,191 |
| 99215 Office E&M - Established | Office | 110 | 63 | $116.96 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 75 | 60 | $11.66 | $874 |
| 99214 Office E&M - Established | Office | 61 | 47 | $81.08 | $4,946 |
| 95885 Electrical Nerve Conductivity | Facility | 48 | 41 | $13.37 | $642 |
| 95913 Electrical Nerve Conductivity | Facility | 32 | 32 | $134.52 | $4,305 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 27 | 24 | $24.54 | $663 |
| 94010 Pulmonary Function Testing | Office | 19 | 16 | $19.03 | $362 |
| 95911 Electrical Nerve Conductivity | Facility | 16 | 16 | $97.64 | $1,562 |
| 99205 Office E&M - New | Office | 14 | 14 | $165.05 | $2,311 |
| 95912 Electrical Nerve Conductivity | Facility | 14 | 14 | $91.98 | $1,288 |
By year: 2022 $48K for 1,064 services; 2023 $35K for 569 services; 2024 $40K for 816 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tawfiq Al Lahham prescribed most often to Medicare patients was Riluzole, with 231 prescriptions and refills. In total Tawfiq Al Lahham wrote 1,037 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Riluzole Generic | 231 | 340 | 61 | $22K |
| Gabapentin Generic | 156 | 240 | 40 | $2,384 |
| Radicava Ors Edaravone | 134 | 134 | 18 | $1.9M |
| Baclofen Generic | 86 | 112 | 16 | $11K |
| Atropine Sulfate Generic | 55 | 60 | 18 | $1,817 |
| Prednisone Generic | 41 | 75 | Under 11 | $187 |
| Pyridostigmine Bromide Generic | 35 | 66 | Under 11 | $1,175 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 53 | Under 11 | $69.24 |
| Relyvrio Sod Phenylbutyrat/Taurursodiol | 28 | 28 | 12 | $369K |
| Tizanidine Hcl Generic | 21 | 29 | Under 11 | $210 |
| Escitalopram Oxalate Generic | 21 | 49 | Under 11 | $401 |
| Scopolamine Generic | 19 | 19 | Under 11 | $1,823 |
| Amitriptyline Hcl Generic | 18 | 30 | Under 11 | $95.86 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 17 | 17 | Under 11 | $289K |
| Mycophenolate Mofetil Generic | 16 | 24 | Under 11 | $969 |
Brand drugs: - claims; generic drugs: 793 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Tawfiq Al Lahham $34.12 ($34.12 in general payments such as food, travel and fees) from 1 company. The largest payer was Alexion Pharmaceuticals, Inc. with $34.12.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 1 | $34.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.